RxDoctor Payments Data

Ubaid Khokhar, MD

Psychiatry · Orange Park, FLNPI 1275713935

Payments from drug & device makers

$7,996in general payments, 2019–2025

Across 477 payments — averaging $16.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Teva Pharmaceuticals USA, Inc.$1K
  • Otsuka America Pharmaceutical, Inc.$988
  • Sunovion Pharmaceuticals Inc.$775
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$506
  • Vanda Pharmaceuticals Inc.$465
  • plus $3K from 18 others

What the payments were for

  • Food & beverage$7,85898%
  • Education$1382%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,996 in reported general payments places this provider in the 85th percentile of 2,059 psychiatry providers in Florida.

See all psychiatry providers in Florida

Medicare billing

Part B allowed, 2024
$60,187
Medicare patients
191
Services billed
523

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Abilify MaintenaAripiprazole39$126,102
Abilify AsimtufiiAripiprazole11$56,281
RexultiBrexpiprazole25$41,295
VraylarCariprazine Hcl11$18,245
Aripiprazole166$16,719
ClozarilClozapine21$12,365
BelsomraSuvorexant14$6,000
Desvenlafaxine Succinate ErDesvenlafaxine Succinate64$4,317
Divalproex Sodium74$4,130
Bupropion XlBupropion Hcl154$3,408
Quetiapine Fumarate129$3,110
Focalin XrDexmethylphenidate Hcl12$2,527
Ziprasidone Hcl44$2,122
Doxepin Hcl37$1,854
Duloxetine Hcl47$1,651

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Abilify Asimtufii, Rexulti$988$223,67875 claims
AbbVieVraylar$1,423$18,24511 claims
MerckBelsomra$117$6,00014 claims
Almatica Pharma LLCSertraline Hcl$14$47172 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,059 psychiatry providers in Florida.

Other psychiatry in Orange Park

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →